Studying the Effect of Temperature on the Tensile Strength of an Intravascular Catheter Using a Degradation Model
Keywords:Accelerated aging, Degradation, First passage time, Intravascular catheter, Wiener process
The accelerated aging process is incorporated into the design and development of intravascular catheters to assess their reliability assuring that this medical device is safe and effective for the intended use during their shelf life. The accelerated aging process is based on a common approach that assumes that the rate of aging increases by a factor of , where is the temperature increment. However, with the life data obtained from this empirical method is difficult to do inferences about reliability. This paper presents an accelerated destructive degradation test using thermal stress to obtain degradation data directly relates reliability to critical performance characteristic, which is the tensile strength in the intravascular catheter tip considered as a critical concern in patients’ safety. The degradation data model is given by a stochastic Wiener process with the drift parameter being represented as Arrhenius function. The parameters of the Wiener process and Arrhenius function are estimated using maximum likelihood; these parameters are used to estimate the first-passage time (time to failure) distribution when the intravascular catheters degradation path reaches a tensile strength critical value in each thermal stress level. Based on this, a complete product reliability assessment is performed and presented.
Hukins DWL, Mahomed A, Kukureka SN. Accelerated aging for testing polymeric biomaterials and medical devices. Med Eng Phys [Internet]. 2008;30(10):1270–1274. Available from: https://doi.org/10.1016/j.medengphy.2008.06.001
Lambert BJ, Tang F-W. Rationale for practical medical device accelerated aging programs in AAMI TIR 17. Radiat Phys Chem [Internet]. 2000;57(3-6):349–353. Available from: https://doi.org/10.1016/S0969-806X(99)00403-X
Clark, GS. Shelf Life of Medical Devices [Internet]. Division of Small Manufacturers Assistance, Office of Training and Assistance, Center for Devices and Radiological Health, Food and Drug Administration; 1991. 31p. Available from: https://www.fda.gov/media/72487/download
Hemmerich KJ. General aging theory and simplified protocol for accelerated aging of medical devices. Met Plast Biomater. 1998;5:16-23.
ASTM International. ASTM F1980-07(2011) Standard Guide for Accelerated Aging of Sterile Barrier Systems for Medical Devices. ASTM International [Internet]; 2016. Available from: https://doi.org/10.1520/F1980-07R11
Sawant M, Christou A. Failure modes and effects criticality analysis and accelerated life testing of LEDs for medical applications. Solid State Electron [Internet]. 2012;78:39–45. Available from: https://doi.org/10.1016/j.sse.2012.05.042
Pan D, Lu S, Liu Y, Yang W, et al. Degradation Data Analysis Using a Wiener Degradation Model with Three-Source Uncertainties. IEEE Access [Internet]. 2019;7:37896–37907. Available from: https://doi.org/10.1109/ACCESS.2019.2906325
Yang G. Lyfe Cycle Reliability Engineering [Internet]. Hoboken: John Wiley & Sons, Inc; 2007. 517p. Available from: http://dx.doi.org/10.1002/9780470117880
Lim H, Yum B-J. Optimal design of accelerated degradation tests based on Wiener process models. J Appl Stat [Internet]. 2011;38(2):309–325. Available from: https://doi.org/10.1080/02664760903406488
Rodríguez-Picón LA, Peréz-Domínguez L, Mejia J, Pérez-Olguín IJ, et al. A Deconvolution Approach for Degradation Modeling with Measurement Error. IEEE Access [Internet]. 2019;7:143899–143911. Available from: http://dx.doi.org/10.1109/access.2019.2945566
Rodríguez-Picón LA, Rodríguez-Picón AP, Alvarado-Iniesta A. Degradation modeling of 2 fatigue-crack growth characteristics based on inverse Gaussian processes: A case study. Appl Stoch Model Bus Ind [Internet]. 2019;35(3):504–521. Available from: http://dx.doi.org/10.1002/asmb.2329
Rodríguez-Picón LA, Flores-Ochoa VH, Méndez-González LC, Rodríguez-Medina MA. Bivariate degradation modelling with marginal heterogeneous stochastic processes. J Stat Comput Simul [Internet]. 2017;87(11):2207–2226. Available from: http://dx.doi.org/10.1080/00949655.2017.1324858
Li T, Pei H, Pang Z, Si X, et al. A Sequential Bayesian Updated Wiener Process Model for Remaining Useful Life Prediction. IEEE Access [Internet]. 2020;8:5471–5480. Available from: http://dx.doi.org/10.1109/ACCESS.2019.2962502
Lyu Y, Zhang Y, Chen K, Chen C, et al. Optimal Multi-Objective Burn-In Policy Based on Time-Transformed Wiener Degradation Process. IEEE Access [Internet]. 2019;7:73529–73539. Available from: http://dx.doi.org/10.1109/ACCESS.2019.2918510
Escobar LA, Meeker WQ, Kugler DL, Kramer LL. Accelerated Destructive Degradation Tests: Data, Models, and Analysis. Series on Quality, Reliability and Engineering Statistics [Internet]. In: Lindvist BH, Doksum KA (eds). Mathematical and Statistical Methods in Reliability. River Edge: World Scientific Publishing Company; 2003. 319–337p. Available from: http://dx.doi.org/10.1142/9789812795250_0021
Tsai C-C, Tseng S-T, Balakrishnan N, Lin C-T. Optimal Design for Accelerated Destructive Degradation Tests. Qual Technol Quant Manag [Internet]. 2013;10(3):263–276. Available from: http://dx.doi.org/10.1080/16843703.2013.11673413
Shi Y, Meeker WQ. Bayesian Methods for Accelerated Destructive Degradation Test Planning. IEEE Trans Reliab [Internet]. 2012;61(1):245–253. Available from: http://dx.doi.org/10.1109/TR.2011.2170115
Shi Y, Escobar LA, Meeker WQ. Accelerated Destructive Degradation Test Planning. Technometrics [Internet]. 2009;51(1):1–13. Available from: http://dx.doi.org/10.1198/TECH.2009.0001
Food and Drug Administration. CFR - Code of Federal Regulations Title 21. Food and Drug Administration [Internet]. 2019. Available from: https://www.fda.gov/medical-devices/medical-device-databases/code-federal-regulations-title-21-food-and-drugs
Food and Drug Administration. Guidance on Premarket Notification [510(k)] Submission for Short-Term and Long-Term Intravascular Catheters. Food and Drug Administration [Internet]. 1995. Available from: https://www.fda.gov/media/72722/download
Food and Drug Administration. Coronary and Peripheral Arterial Diagnostic Catheters - Guidance for Industry and FDA Staff. Food and Drug Administration [Internet]. 2003. Available from: https://www.fda.gov/media/71373/download
Food and Drug Administration. Peripheral Percutaneous Transluminal Angioplasty (PTA) and Specialty Catheters - Premarket Notification (510(k)) Submissions. Food and Drug Administration [Internet]. 2020. Available from: https://www.fda.gov/media/134016/download
Food and Drug Administration. MDR - Medical Device Recalls. Food and Drug Administration [Internet]. 2020. Available from: https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfRES/res.cfm
Food and Drug Administration. MAUDE - Manufacturer and User Facility Device Experience. Food and Drug Administration [Internet]. 2020. Available from: https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfMAUDE/search.CFM
Lanzer P. Mastering Endovascular Techniques: A Guide to Excellence. Baltimore: Lippincott Williams & Wilkins; 2006. 480p.
International Organization Standardisation (ISO). ISO 10555-1: Intravascular catheters — Sterile and single-use catheters — Part 1: General requirements. Geneva, Switzerland: International Organization for Standardisation. 2013. 24p.
Kahle W, Mercier S, Paroissin C. Degradation Processes in Reliability [Internet]. New Jersey: John Wiley & Sons; 2016. 211p. Available from: http://dx.doi.org/10.1002/9781119307488
GNU. The R Project for Statistical Computing R [Internet]. 2016. Available from: https://www.R-project.org/
How to Cite
Copyright (c) 2022 Revista Mexicana de Ingeniería Biomédica
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Upon acceptance of an article in the RMIB, corresponding authors will be asked to fulfill and sign the copyright and the journal publishing agreement, which will allow the RMIB authorization to publish this document in any media without limitations and without any cost. Authors may reuse parts of the paper in other documents and reproduce part or all of it for their personal use as long as a bibliographic reference is made to the RMIB. However written permission of the Publisher is required for resale or distribution outside the corresponding author institution and for all other derivative works, including compilations and translations.